Lipid nanoparticle compositions and uses thereof
US12337068B2 · kind B2 · utility
0Cited by
11References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2024 |
| Grant date | Jun 24, 2025 |
| Priority date | — |
| Expiry date | Sep 16, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/705
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are methods for delivering lipid nanoparticles (LNPs) to a lung cell of a subject suffering from or at risk for primary ciliary dyskinesia (PCD), wherein the method comprises nebulizing a liquid pharmaceutical composition to generate an aerosolized pharmaceutical composition, and administering the aerosolized pharmaceutical composition to the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.